Uphill Battle of CRISPR/Cas9: A Budding Technology in Need of Refinement

Authors

  • Gen Kaneko Department of Biology, University of Houston-Victoria, 3007, N. Ben Wilson, Victoria, TX 77901
  • Crystal Salinas Department of Biology, University of Houston-Victoria, 3007, N. Ben Wilson, Victoria, TX 77901
  • Hashimul Ehsan Department of Biology, University of Houston-Victoria, 3007, N. Ben Wilson, Victoria, TX 77901

Keywords:

CRISPR/Cas9, gene-editing technology, genomics, bioethics, media portrayal, regulations, enhancement, germline alterations

Abstract

CRISPR/Cas9 has been a discovery that has developed advancements in the field of genetic engineering. This technology revolutionized genome editing by its ease of manipulation, high efficiency and broad range of applications within a number of hosts and a variety of diseases. Scientists have invested a lot of their attention in this system to reap the beneficial consequences of genome manipulation in animal cells. CRISPR has potential that we have yet to consider or uncover, but this is just the steppingstone to something far more than a system of genomic modification. It is still in its infancy, and thus far, there has been many developments since its discovery. To date, CRISPR/Cas9 requires refinement to hone its accuracy of delivery and safety. Its application to many different diseases, ranging from abnormal cell growth to neurodegenerative disorders, reveals an amalgamation of results, both positive and negative in outcome. This reveals the climate surrounding CRISPR/Cas9 progress.

Downloads

Published

26-07-2022

How to Cite

Kaneko, G., Salinas, C., & Ehsan, H. (2022). Uphill Battle of CRISPR/Cas9: A Budding Technology in Need of Refinement. Bioresearch Communications - (BRC), 6(1), 859–871. Retrieved from https://www.bioresearchcommunications.com/index.php/brc/article/view/51

Issue

Vol. 6 No. 1 (2020)

Section

Review Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author(s) will retain the copyright of their own articles. By submitting the article to Bioresearch Communications (BRC), the author(s) have granted the BRC for the use of the article.